Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
van den Hoogen, Lotus LSmits, Gaby
van Hagen, Cheyenne C E
Wong, Denise
Vos, Eric R A
van Boven, Michiel
de Melker, Hester E
van Vliet, Jeffrey
Kuijer, Marjan
Woudstra, Linde
Wijmenga-Monsuur, Alienke J
GeurtsvanKessel, Corine H
Stoof, Susanne P
Reukers, Daphne
Wijsman, Lisa A
Meijer, Adam
Reusken, Chantal B E M
Rots, Nynke Y
van der Klis, Fiona R M
van Binnendijk, Robert S
den Hartog, Gerco
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?Published in
Vaccine 2022; 40(15):2251-7PMID
35287986ae974a485f413a2113503eed53cd6c53
10.1016/j.vaccine.2022.03.009
Scopus Count
Collections
Related articles
- Increasing Levels of Serum Anti-Spike S1-RBD IgG after 120 Days of the Pfizer-BioNTech-mRNA Second Dose Vaccination.
- Authors: Abdul-Wahab Kadhum A, Rushdi Abdullah A, Mujahid A
- Issue date: 2023 Jun
- Use of Self-Collected Dried Blood Spots and a Multiplex Microsphere Immunoassay to Measure IgG Antibody Response to COVID-19 Vaccines.
- Authors: Nemeth KL, Yauney E, Rock JM, Bievenue R, Parker MM, Styer LM
- Issue date: 2023 Feb 14
- Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
- Authors: Desmecht S, Tashkeev A, El Moussaoui M, Marechal N, Perée H, Tokunaga Y, Fombellida-Lopez C, Polese B, Legrand C, Wéry M, Mni M, Fouillien N, Toussaint F, Gillet L, Bureau F, Lutteri L, Hayette MP, Moutschen M, Meuris C, Vermeersch P, Desmecht D, Rahmouni S, Darcis G
- Issue date: 2022
- Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals.
- Authors: Sembera J, Baine C, Ankunda V, Katende JS, Oluka GK, Akoli CH, Kato L, Odoch G, Ejou P, Opio S, Musenero M, COVID-19 Immunoprofiling Team, Kaleebu P, Serwanga J
- Issue date: 2023
- Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
- Authors: Garrett ME, Galloway JG, Wolf C, Logue JK, Franko N, Chu HY, Matsen FA 4th, Overbaugh JM
- Issue date: 2022 Jan 24